Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMTX
AMTX logo

AMTX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Aemetis Inc (AMTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.840
1 Day change
-0.81%
52 Week Range
3.800
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Aemetis Inc (AMTX) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators show no clear upward momentum, and there are no significant positive catalysts or trading signals to support an immediate purchase. Given the lack of news, financial data, and strong trading sentiment, it is better to hold off on investing in this stock for now.

Technical Analysis

The MACD is below zero and negatively contracting (-0.0315), indicating weak momentum. RSI is neutral at 30.731, and moving averages are converging, suggesting no clear trend. The stock is trading below the pivot level (2.112) but above the first support (1.887), showing limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
3

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

  • The stock has a 60% chance of declining by 10.25% in the next day, and technical indicators do not suggest a strong upward trend. No recent congress trading data or financial performance data is available.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target updates available.

Wall Street analysts forecast AMTX stock price to rise
1 Analyst Rating
Wall Street analysts forecast AMTX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.860
sliders
Low
20
Averages
20
High
20
Current: 1.860
sliders
Low
20
Averages
20
High
20
UBS
Manav Gupta
maintain
$3
AI Analysis
2025-06-30
Reason
UBS
Manav Gupta
Price Target
$3
AI Analysis
2025-06-30
maintain
Reason
UBS analyst Manav Gupta raised the firm's price target on Aemetis to $3 from $2.20 and keeps a Buy rating on the shares. Aemetis announced that the California Air Resources Board has approved provisional pathways under the Low Carbon Fuel Standard for seven dairy digesters built and operated by Aemetis Biogas, which are effective as of January 1, 2025, the analyst tells investors in a research note.

People Also Watch